In an adult with suspected acute myocardial infarction, what is the recommended immediate evidence‑based treatment and reperfusion strategy?

Immediate Management of Acute Myocardial Infarction

For an adult with suspected acute MI, immediately obtain a 12-lead ECG within 10 minutes, administer 162–325 mg chewed aspirin, initiate continuous cardiac monitoring with defibrillator capability, and proceed directly to primary PCI if achievable within 90 minutes of first medical contact—otherwise administer fibrinolytic therapy within 30 minutes if PCI cannot be performed within 120 minutes. 1, 2

Initial Assessment (First 10 Minutes)

• Obtain a 12-lead ECG within 10 minutes of arrival to identify ST-segment elevation ≥1 mm in contiguous leads or new left bundle branch block, which indicates need for immediate reperfusion 1, 2
• Administer 162–325 mg aspirin orally (chewed) immediately—this is the single most important early pharmacologic intervention 2, 3
• Place patient on continuous cardiac monitoring with bedside defibrillator and ACLS capability to detect life-threatening arrhythmias 2, 3
• Assess oxygen saturation and provide supplemental oxygen only if SaO₂ <90% or PaO₂ <60 mmHg—routine oxygen in normoxemic patients (SaO₂ ≥90%) is not recommended and may increase myocardial injury (Class III harm) 1, 2

Reperfusion Strategy: The Critical Decision

Primary PCI is the preferred reperfusion method when it can be performed with first medical contact-to-device time ≤90 minutes at a PCI-capable hospital, or ≤120 minutes if transfer from a non-PCI-capable facility is required 1, 2. This recommendation is based on the superiority of mechanical reperfusion over pharmacologic therapy in multiple trials 1.

When to Choose Primary PCI:

• Door-to-balloon time achievable within 90 minutes at PCI-capable facility 1, 2
• Transfer time allows FMC-to-device within 120 minutes from non-PCI-capable facility 1
• Any patient with cardiogenic shock or acute severe heart failure, regardless of time delay 1
• Contraindications to fibrinolytic therapy exist 1

When to Choose Fibrinolytic Therapy:

• Primary PCI cannot be achieved within 120 minutes of first medical contact 1, 2
• Door-to-needle time can be achieved within 30 minutes 1, 2
• Symptom onset is within 12 hours (greatest benefit within first 6 hours) 1, 4
• No contraindications to fibrinolysis exist (see FDA label for tenecteplase contraindications: active internal bleeding, history of CVA, intracranial surgery/trauma within 2 months, intracranial neoplasm/AVM/aneurysm, known bleeding diathesis, severe uncontrolled hypertension) 5

Critical time-dependent benefit: Reperfusion therapy saves approximately 35 lives per 1,000 patients when initiated within the first hour, declining to 16 lives per 1,000 when given between 7–12 hours after symptom onset 4. Beyond 12 hours, benefit is minimal unless ongoing ischemia persists 4.

Immediate Pharmacologic Management

• Administer sublingual nitroglycerin (up to 3 doses, 5 minutes apart) unless systolic BP <90 mmHg or heart rate <50 or >100 bpm 2, 4, 3
• Give P2Y12 inhibitor immediately: ticagrelor or prasugrel preferred over clopidogrel 2, 3
• Administer anticoagulation based on reperfusion strategy:
  • For primary PCI: unfractionated heparin (preferred), or enoxaparin/bivalirudin as alternatives 2
  • For fibrinolysis: enoxaparin is preferred, with unfractionated heparin as alternative 2
• Provide intravenous morphine for pain control if needed, titrated to effect (note: may delay oral antiplatelet absorption) 2, 3

Transfer and System Organization

For patients at non-PCI-capable facilities, immediate transfer is mandatory with a door-in-door-out (DIDO) time ≤30 minutes to achieve the FMC-to-device goal of ≤120 minutes 1. The American College of Cardiology explicitly states that EMS transport should bypass non-PCI-capable facilities and go directly to PCI-capable centers when feasible 1, 2.

High-Risk Patients Requiring Immediate Transfer:

• Anterior MI 4
• Cardiogenic shock 1, 4
• Pulmonary congestion/acute heart failure 1, 4
• Heart rate >100 bpm 4
• Systolic BP <100 mmHg 4

Critical pitfall: Do not delay treatment for insurance authorization or administrative procedures—these must never postpone definitive therapy 2, 4.

Post-Fibrinolysis Management

If fibrinolytic therapy is administered, routine early angiography within 3–24 hours is recommended rather than waiting for ischemia-driven indications 1. However, avoid catheterization within 2–3 hours of fibrinolytic administration due to increased bleeding risk 4. For failed reperfusion or reocclusion, urgent transfer for rescue PCI is indicated 1.

Special Considerations and Common Pitfalls

• Atypical presentations (severe epigastric pain, unexplained dyspnea, indigestion) should trigger the full MI protocol—one-third of MI patients present without chest discomfort, and this group has 2.2-fold higher mortality (23.3% vs 9.3%) 2, 4
• Do not wait for cardiac biomarkers in patients with ST-elevation or new LBBB—ECG findings alone warrant immediate reperfusion 4
• Do not send patients to physician offices—transport directly to hospitals with 24-hour emergency cardiac care and catheterization capability 2, 4
• Critically ill patients (cardiac arrest, recurrent ventricular arrhythmias, severe bradycardia) should be triaged to facilities with both catheterization labs and cardiac surgery capabilities 2
• Patients presenting >12 hours after symptom onset should still receive immediate medical therapy (aspirin, antiplatelet agents, anticoagulation) even if reperfusion is not indicated 4